Owl Manor is a privately held medical device company dedicated to companion animal joint and soft tissue preservation through advanced lameness technologies.
Mark Schindel, CEO, Board of Managers, Co-Founder
Mark Schindel is a medical technology executive experienced in marketing, sales, business development, strategic planning, and project management in both early-stage and established corporate environments. Mark’s experience spans the life science, biotech, and medical device industries, including positions at Tornier, Zimmer, Biomet, and Roche. Mark holds a B.S. from Purdue University and an MBA from Vanderbilt University.
Mike Leach, COO, Co-Founder
Mike Leach has over 20 years of experience in design, development, and operations within the medical device industry with Biomet. Mike began his career in the aerospace industry. Mike is a co-inventor on more than 40 patents and 60-plus patent applications. Mike has a B.S. degree from Grace College.
Bill King, Director of Research, Development, and Clinical
Bill King, PhD, has over 15 years of experience in regenerative medicine, medical device development, and clinical research, including prior work in the medical device industry at Biomet. Bill has published numerous scientific articles on stem cells, biomaterials, and osteoarthritis. Bill holds a B.S. in Bioengineering from University of Toledo and M.S. and PhD in Biomedical Engineering from the University of Wisconsin-Madison. Bill performed post-doctoral research at the University of Michigan.
Scott King, Board of Managers, Co-Founder
Scott King is Founder and President of Hanuman Medical, creating and patenting new medical technologies. In addition to founding and managing Islet Sheet Medical and PlasmaSeal, Scott was Wall Street’s first biotechnology industry analyst. Scott was educated at the College of the University of Chicago (S.B.) and Harvard University (M.A.).
Randy Dorian, Co-Founder
Randy Dorian has four decades of experience in academic and industrial research and development. He has served in senior level research positions, including EVP at Hanuman Medical, CSO at Cerco Medical, SVP at PlasmaSeal, and Sr Scientist / Director at Transtech Medical. With expertise in biotechnology, biochemistry, applied mathematics, bioengineering design and fabrication, Randy holds nearly 50 patents and has authored numerous academic papers.
Rick Storrs, Co-Founder
Rick Storrs, PhD, has over 20 years of experience in cell biology, design, and engineering across industry and academia. Prior roles include VP R&D at Hanuman Medical, and as COO at Cerco Medical, Sr. Scientist at Plasmaseal, and Lead Scientist at DepoTech. Rick is a co-inventor of more than a dozen patented technologies and author of numerous peer-reviewed papers. Rick was trained as a protein chemist at University of California, Berkeley (PhD) and drug delivery scientist (NIH Postdoctoral Fellow, Stanford).